We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WALMEX:BMVWal-Mart de Mexico SAB de CV Analysis

Data as of 2026-05-18 - not real-time

MX$56.07

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Walmex is trading around MXN 56, which sits below the consensus 12‑month target of roughly MXN 65, implying a mid‑teens upside despite a DCF‑derived fair value that suggests the stock may be undervalued. Technical indicators show the price below the 20‑day, 50‑day and 200‑day moving averages, confirming a bearish trend, yet the MACD histogram has turned positive and the RSI hovers near the neutral 50 mark, hinting at a potential short‑term bounce. The dividend yield of about 3.7% and a payout ratio under 60% reinforce the stock’s appeal for income‑focused investors. Volatility is moderate at roughly 25% over the past 30 days, while a beta near 0.2 signals limited sensitivity to broader market moves, keeping overall market risk low. Recent news highlights a planned MXN 2.4 billion capex program and a 14% surge in e‑commerce sales, underscoring continued investment in growth channels. Analyst sentiment remains positive, with a “Buy” consensus from 18 analysts and a median price target of MXN 65.5.
Fundamentally, the company delivers solid profitability – operating margins near 7.5% and ROE around 20% – and generates robust cash flow, evidenced by free cash flow exceeding MXN 36 billion. The modest revenue growth of 1.7% is complemented by strong same‑store performance and expanding online demand, particularly in the on‑demand segment. A healthy balance sheet, low leverage (debt‑to‑equity ~32) and ample liquidity support the ongoing dividend and capital‑intensive initiatives. The defensive consumer‑staples positioning, combined with attractive yields and upside potential, makes Walmex a compelling candidate for investors seeking a blend of income and modest growth.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support level
  • Bearish trend despite marginal MACD bullish signal
  • Attractive dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst price targets indicating ~15% upside
  • Strong cash generation and sustainable dividend
  • Capex and e‑commerce initiatives driving future earnings

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Defensive consumer‑staples positioning in Mexico and Central America
  • Consistent profitability and high ROE
  • Long‑term dividend sustainability and growth potential

Key Metrics & Analysis

Financial Health

Revenue Growth1.70%
Profit Margin4.93%
P/E Ratio19.5
ROE20.19%
ROA10.00%
Debt/Equity32.18
P/B Ratio4.1
Op. Cash FlowMX$91.8B
Free Cash FlowMX$36.9B

Technical Analysis

TrendBearish
RSI50.8
SupportMX$52.60
ResistanceMX$57.84
MA 20MX$55.30
MA 50MX$56.40
MA 200MX$57.57
MACDBullish
VolumeStable
Fear & Greed Index89.61

Valuation

Fair ValueMX$26.77
Target PriceMX$65.32
Upside/Downside16.49%
GradeUndervalued
TypeValue
Dividend Yield3.67%

Risk Assessment

Beta0.19
Volatility25.61%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.